Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
Alignment to the key priorities, the four core programs.
Qual é a melhor parte das suas compensações?
The salary is the best part of the compensation package.
O que você mais gosta nos lideres?
The ET has the best interest of the company in mind, aligned with the key priorities.
Quais são algumas das melhores coisas da sua equipe?
They all have the best intentions, doing what they can to make Karyopharm a better place.
Other Employee Reviews for Karyopharm Therapeutics
×